FDA Approved: UPTRAVI — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

The FDA lists a supplemental application for UPTRAVI (selexipag) filed by Actelion Pharmaceuticals US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Uptravi (selexipag)

Snippet

SUPPL AP for UPTRAVI (SELEXIPAG)